Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medvest
AddedFeb 15, 2024
UpdatedJun 28, 2026
Medvest

Medvest

UK-based Medvest funds medical projects, guides entrepreneurs, and seeks progressive investors for early biotech/medical industry ventures.

HQ
London, Greater London, GB
Founded
2010
Overview
Compare
Employees
Website

Founded in London, UK, Medvest is dedicated to funding medical projects and guiding entrepreneurs through the commercialization process or pre-phase III clinical trials. With a presence in both London and Tel-Aviv, the organization focuses on early-stage biotech and medical industry ventures. Medvest's core mission is to support innovative medical technologies by providing financial backing and professional guidance, ultimately aiming to bring promising medical solutions to market.

Medvest is supported by four partners and a professional consulting team renowned for their expertise in recognizing, funding, and closing technology deals. The organization has built a strong reputation for its ability to identify high-potential medical projects and successfully guide them through critical development stages. By fostering collaborations between entrepreneurs and progressive investors, Medvest has made a significant impact on advancing medical innovations and improving healthcare outcomes.

Medvest - Quick Facts

When was Medvest founded?

Medvest was founded in 2010.

Where is Medvest's headquarters located?

Medvest's headquarters is located in London, Greater London, GB.

How many employees does Medvest have?

Medvest has 6 employees as of Feb 4, 2024.

Medvest - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Europe
Customer
  • Enterprise
Main Product
  • Medical Funding
Tags
  • Financial
  • Healthtech